{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:46:36Z","timestamp":1791398796316,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152257","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T21:06:41Z","timestamp":1692652001000},"page":"152257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-3738","authenticated-orcid":false,"given":"Anji","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiquan","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.semarthrit.2023.152257_bib0001","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"issue":"10103","key":"10.1016\/j.semarthrit.2023.152257_bib0002","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"10188","key":"10.1016\/j.semarthrit.2023.152257_bib0003","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2023.152257_bib0004","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","author":"Fragoulis","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152257_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152257_bib0006","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152257_bib0007","doi-asserted-by":"crossref","first-page":"w14281","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0008","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152257_bib0009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semarthrit.2014.06.001","article-title":"Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis","volume":"44","author":"Wang","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-019-1851-9","article-title":"Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors","volume":"21","author":"Lao","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001508","article-title":"Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases","volume":"7","author":"Ishikawa","year":"2021","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152257_bib0012","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl_1","key":"10.1016\/j.semarthrit.2023.152257_bib0014","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152257_bib0015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152257_bib0016","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152257_bib0017","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2169\/internalmedicine.8205-21","article-title":"Factors associated with pneumocystis Jirovecii pneumonia in patients with rheumatoid arthritis receiving methotrexate: a single-center retrospective study","volume":"61","author":"Ohmura","year":"2022","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152257_bib0018","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10067-022-06403-9","article-title":"Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study","volume":"42","author":"Li","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152257_bib0019","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/acr.24584","article-title":"Pneumocystis Jirovecii pneumonia in systemic lupus Erythematosus: a nationwide cohort study in Taiwan","volume":"74","author":"Wang","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152257_bib0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/rheumatology\/keaa436","article-title":"Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America","volume":"60","author":"Sabbagh","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0021","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-021-02606-8","article-title":"High incidence and mortality of Pneumocystis Jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center","volume":"23","author":"Huang","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152257_bib0022","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1007\/s10067-021-05660-4","article-title":"Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study","volume":"40","author":"Hsu","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12879-020-4826-1","article-title":"Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study","volume":"20","author":"Yeo","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0024","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-019-1996-6","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152257_bib0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.semarthrit.2018.05.013","article-title":"Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: a nested case-control study","volume":"48","author":"Nunokawa","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152257_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/RHU.0000000000000731","article-title":"Risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of trimethoprim\/sulfamethoxazole","volume":"24","author":"Yukawa","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0027","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.semarthrit.2016.09.009","article-title":"Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: a case-control study","volume":"46","author":"Tadros","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0028","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar4472","article-title":"Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study","volume":"16","author":"Katsuyama","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0029","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3109\/s10165-012-0796-5","article-title":"Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients","volume":"23","author":"Watanabe","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/s10165-012-0615-z","article-title":"Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors","volume":"22","author":"Tanaka","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152257_bib0031","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-008-0721-6","article-title":"Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus","volume":"29","author":"Lertnawapan","year":"2009","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152257_bib0032","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152257_bib0033","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/s10165-006-0502-6","article-title":"Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease","volume":"16","author":"Iikuni","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152257_bib0034","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s10067-020-05068-6","article-title":"Infective patterns of cryptococcosis in patients with connective tissue disease: a retrospective study","volume":"39","author":"Lao","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0961203318817118","article-title":"Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study","volume":"28","author":"Lao","year":"2019","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152257_bib0036","first-page":"S55","article-title":"Invasive fungal infections in Colombian patients with systemic lupus erythematosus","volume":"24","author":"Santamar\u00eda-Alza","year":"2018","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152257_bib0037","doi-asserted-by":"crossref","first-page":"e5531","DOI":"10.1590\/1414-431x20165531","article-title":"Invasive pulmonary fungal infections in patients with connective tissue disease: a retrospective study from northern China","volume":"49","author":"Ge","year":"2016","journal-title":"Braz J Med Biol Res"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152257_bib0038","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3899\/jrheum.150142","article-title":"A multicenter study of invasive fungal infections in patients with childhood-onset systemic lupus erythematosus","volume":"42","author":"Silva","year":"2015","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152257_bib0039","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0961203313496342","article-title":"Invasive fungal infections in Argentine patients with systemic lupus erythematosus","volume":"22","author":"Vinicki","year":"2013","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152257_bib0040","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3899\/jrheum.111498","article-title":"Invasive fungal infections in patients with systemic lupus erythematosus","volume":"39","author":"Mart\u00ednez-Mart\u00ednez","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152257_bib0041","first-page":"313","article-title":"Invasive fungal infections in seniors with rheumatoid arthritis: a population-based study from the Ontario Biologics Research initiative","volume":"62","author":"Widdifield","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152257_bib0042","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152257_bib0043","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/infdis\/jit103","article-title":"Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease","volume":"207","author":"Henriet","year":"2013","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152257_bib0044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152257_bib0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","article-title":"Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152257_bib0047","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152257_bib0048","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/annrheumdis-2017-212861","article-title":"Trimethoprim-sulfamethoxazole prophylaxis prevents severe\/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis","volume":"77","author":"Kronbichler","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152257_bib0049","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","article-title":"Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented?","volume":"19","author":"Wolfe","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152257_bib0050","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3899\/jrheum.090153","article-title":"Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review","volume":"37","author":"Bourre-Tessier","year":"2010","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:51Z","timestamp":1758733851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S0049017223000999"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152257","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152257"}}